Sildenafil

sildenafil citrate

Sildenafil is a PDE5 inhibitor best known for treating erectile dysfunction and pulmonary hypertension. Recent observational data linking it to lower Alzheimer disease incidence has driven exploratory interest in its endothelial and cerebrovascular effects as a healthspan intervention.

PDE5 inhibitorPrescription requiredEvidence C
⚠ Not medical advice.Not medical advice. This page is educational. Discuss with your physician before starting, changing, or stopping any medication.

Why it matters

Sildenafil sits at the intersection of approved use and longevity speculation. By inhibiting phosphodiesterase type 5, sildenafil potentiates nitric oxide signaling and produces vasodilation — most prominently in penile and pulmonary vasculature, but with measurable effects on systemic endothelial function (Circulation 2002, Desouza). The Nature Aging 2021 paper by Fang et al analyzed US insurance claims data on 7.2 million patients and found sildenafil users had roughly 70% lower incidence of Alzheimer disease over six years. Subsequent claims database analyses have produced similar signals. These findings are observational, subject to healthy-user bias, and have not been confirmed in randomized trials. Cardiovascular safety data from large observational cohorts in men with diabetes (J Sex Med 2017) suggest neutral-to-favorable effects in users without contraindications. For high-performance men, sildenafil is a well-established treatment for ED with potential pleiotropic effects on endothelial function, exercise tolerance at altitude (Ann Intern Med 2004), and possibly long-term cognitive risk — though the evidence grade for these latter uses remains low.

Uses

Label uses (approved)
  • Erectile dysfunction
  • Pulmonary arterial hypertension (Revatio)
Off-label (educational only)
  • Cardiovascular / endothelial health — Improves flow-mediated dilation and endothelial function in observational and small RCT datamoderate
  • Alzheimer disease risk reduction — Observational claims database studies (Nature Aging 2021) suggest reduced AD incidence in usersweak
  • Altitude sickness and exercise performance at altitude — Improves pulmonary vasodilation and VO2 at altitudemoderate

Dosing

Label dose
25-100 mg as needed, 30-60 minutes before sexual activity (max once daily). Revatio: 20 mg three times daily
Off-label / biohacker dose
Low daily dose 25 mg for endothelial/longevity rationale (off-label, limited evidence)
Titration: Start 50 mg as needed for ED; titrate to 100 mg if needed, 25 mg if elderly or hepatic impairment. Daily low-dose use is off-label and not supported by outcome data.
When to take: For ED: 30-60 minutes before activity, with or without food (high-fat meals delay onset). For PAH: three times daily.

Side effects & warnings

Common
  • Headache
  • Flushing
  • Nasal congestion
  • Dyspepsia
  • Visual disturbances (blue tinge, brightness)
  • Back pain
  • Myalgia
Uncommon but serious
  • Priapism (erection >4 hours, surgical emergency)
  • Non-arteritic anterior ischemic optic neuropathy (NAION, rare)
  • Sudden sensorineural hearing loss (rare)
  • Severe hypotension (with nitrates, contraindicated)
  • Rare allergic reactions
Serious warnings
Absolutely contraindicated with any nitrate (nitroglycerin, isosorbide) — combination produces life-threatening hypotension. Caution with alpha blockers (additive hypotension) and other antihypertensives. Priapism (erection lasting more than 4 hours) is a medical emergency requiring immediate intervention to prevent permanent ED. NAION (non-arteritic anterior ischemic optic neuropathy) is rare but can cause permanent vision loss; risk higher in men with small optic disc cup, diabetes, and cardiovascular risk factors. Avoid in recent stroke, unstable angina, hypotension, or severe hepatic impairment.

Biomarkers affected

blood pressure
decrease
Mild systemic BP reduction (~10/5 mmHg) via vasodilation
Evidence: moderate
hscrp
variable
Mixed data on endothelial inflammation markers
Evidence: weak
resting hr
variable
Variable; modest reflex tachycardia in some users
Evidence: weak
vo2 max
increase
Improves VO2 at altitude via pulmonary vasodilation (Ann Intern Med 2004)
Evidence: moderate

Monitoring

Blood pressure if used regularly; cardiovascular risk assessment before sustained use

The honest risk picture

## What can go wrong **Headache, flushing, and nasal congestion** are the most common side effects, affecting 15-25% of users. Usually mild and dose-dependent. **Visual disturbances** — blue tinge, brightness, photosensitivity — occur because sildenafil weakly inhibits PDE6 in retinal photoreceptors. Usually transient and harmless. **Priapism** (erection lasting more than 4 hours) is a urological emergency. Prolonged ischemia causes permanent ED. Risk is higher with sickle cell disease, multiple myeloma, and leukemia. **Non-arteritic anterior ischemic optic neuropathy (NAION)** is a rare but potentially permanent cause of vision loss. Risk concentrates in men with small optic disc cup, diabetes, hypertension, and prior NAION in the other eye. **Sudden sensorineural hearing loss** has been reported, sometimes permanent. Discontinue immediately if it occurs. **Severe hypotension** with concurrent nitrate use is absolutely contraindicated — can be fatal. This includes recreational amyl nitrite (poppers). Caution with alpha blockers. **Cardiovascular events during sexual activity** are not caused by sildenafil per se, but unmasked cardiovascular disease can present this way. Men with significant CAD should be evaluated before regular use. **Drug interactions** include strong CYP3A4 inhibitors (ketoconazole, ritonavir) — reduce dose substantially.

Practical context

Cost (US, retail)
$30/mo
Legality
Prescription-only in US, EU, UK. Generic and inexpensive. OTC in some EU countries.
Interactions
true

FAQ

Does sildenafil really reduce Alzheimer risk?+
A 2021 Nature Aging paper by Fang et al found sildenafil users in US insurance claims had ~70% lower Alzheimer incidence over 6 years. This is observational data subject to confounding; no randomized trial has yet replicated it.
Is daily low-dose sildenafil safe?+
Probably, in healthy men without nitrate use or severe cardiovascular disease. Evidence for benefit at this dose is limited. Most longevity-oriented use is speculative.
Can I take sildenafil before exercise?+
Possibly beneficial at altitude (improves pulmonary vasodilation and VO2 max above 4000m). At sea level, evidence for performance benefit is weak.
Will it lower my blood pressure dangerously?+
Mild BP reduction (around 10/5 mmHg) is normal. Dangerous hypotension occurs only with nitrates or strong alpha blockers.
How long does it last?+
Sildenafil half-life is ~4 hours; functional effect ~4-6 hours. Tadalafil (Cialis) lasts much longer (~36 hours) and is more commonly used for daily low-dose protocols.
References (4)+
  1. Sildenafil use and reduced risk of Alzheimer disease (Fang et al). Nature Aging 2021. https://pubmed.ncbi.nlm.nih.gov/34888528/
  2. PDE5 inhibitors and cardiovascular outcomes in men with type 2 diabetes. J Sex Med 2017. https://pubmed.ncbi.nlm.nih.gov/29032972/
  3. Effects of sildenafil on endothelial function in men. Circulation 2002 (Desouza et al). https://pubmed.ncbi.nlm.nih.gov/11827928/
  4. Sildenafil for high-altitude pulmonary hypertension and exercise performance. Ann Intern Med 2004. https://pubmed.ncbi.nlm.nih.gov/15023708/
The prime report

Weekly performance intelligence.

New studies, protocols, and optimization frameworks delivered every Monday. No fluff, no motivation quotes — only what moves the needle.

No spam. Unsubscribe anytime.